Hasslacher, C., Kulozik, F., & Lorenzo Bermejo, J. (2016). Treatment with insulin analogs, especially Glargine and Lispro, associates with better renal function and higher hemoglobin levels in Type 1 diabetic patients with impaired kidney function: $hChristoph Hasslacher, Felix Kulozik, Justo Lorenzo Bermejo. Therapeutic advances in endocrinology and metabolism, 7(4), . https://doi.org/10.1177/2042018816644393
Chicago Style (17th ed.) CitationHasslacher, Christoph, Felix Kulozik, and Justo Lorenzo Bermejo. "Treatment with Insulin Analogs, Especially Glargine and Lispro, Associates with Better Renal Function and Higher Hemoglobin Levels in Type 1 Diabetic Patients with Impaired Kidney Function: $hChristoph Hasslacher, Felix Kulozik, Justo Lorenzo Bermejo." Therapeutic Advances in Endocrinology and Metabolism 7, no. 4 (2016). https://doi.org/10.1177/2042018816644393.
MLA (9th ed.) CitationHasslacher, Christoph, et al. "Treatment with Insulin Analogs, Especially Glargine and Lispro, Associates with Better Renal Function and Higher Hemoglobin Levels in Type 1 Diabetic Patients with Impaired Kidney Function: $hChristoph Hasslacher, Felix Kulozik, Justo Lorenzo Bermejo." Therapeutic Advances in Endocrinology and Metabolism, vol. 7, no. 4, 2016, https://doi.org/10.1177/2042018816644393.